Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China

Authors

  • Lei Chen Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China https://orcid.org/0000-0003-2716-4454
  • Min Zhang Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China https://orcid.org/0000-0003-2716-4454
  • Yiwen Wang Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
  • Zhi Li Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
  • Yu Yang Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
  • Zhirong Wang Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
  • Yuan Lu Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China https://orcid.org/0000-0003-2716-4454

DOI:

https://doi.org/10.3855/jidc.16747

Keywords:

COVID-19, acute myocardial infarction, urban areas, rural areas, MACEs

Abstract

Introduction: The treatment of acute myocardial infarction (AMI) during the COVID-19 pandemic has been affected to varying degrees. This study is the first to explore the impact of COVID-19 on the treatment and prognosis of rural and urban AMI in developing countries.

Methodology: A total of 128 patients with AMI in our hospital during the COVID-19 pandemic were enrolled. A total of 197 patients diagnosed with AMI before the COVID-19 pandemic were selected as the control group and one year of follow-up was performed.

Results: Hospital stay and the proportion of Killip class ≥ 2 patients were increased among rural AMI patients in the ‘during COVID-19’ group, compared with the ‘before COVID-19’ group. Among ST-segment elevation myocardial infarction (STEMI) total and rural STEMI patients, the treatment time in the during-COVID-19 group was longer than that in the before-COVID-19 group, whereas only the symptom to door (S to D) total and door to balloon (D to B) were extended in urban STEMI patients. In AMI total and rural AMI patients, major adverse cardiovascular events (MACEs) and all-cause mortality were increased in the during-COVID-19 group compared with the before-COVID-19 group. Kaplan–Meier analysis revealed that the survival and occurrence of MACEs in AMI total and rural AMI patients were significantly higher in the during-COVID-19 group.

Conclusions: The COVID-19 pandemic led to delayed treatment and worse prognosis in AMI patients. Rural areas appear to be at a greater risk.

Downloads

Published

2022-09-30

How to Cite

1.
Chen L, Zhang M, Wang Y, Li Z, Yang Y, Wang Z, Lu Y (2022) Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China. J Infect Dev Ctries 16:1417–1423. doi: 10.3855/jidc.16747

Issue

Vol. 16 No. 09: September 2022

Section

Coronavirus Pandemic

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC